Glaukos (GKOS) Change in Accured Expenses (2014 - 2026)

Glaukos' (GKOS) quarterly Change in Accured Expenses came in at -$10.2 million in Q1 2026, down 51.46% year-on-year from -$21.0 million in Q1 2025, and down 191.51% on a QoQ basis from $11.1 million in Q4 2025.

Glaukos (GKOS) Change in Accured Expenses (2014 - 2026) Analysis & Trends

Glaukos (GKOS) has 13 years of Change in Accured Expenses data on file, last reported at -$10.2 million in Q1 2026.

  • On a quarterly basis, Change in Accured Expenses fell 51.46% year-over-year to -$10.2 million in Q1 2026; TTM through Mar 2026 was $15.4 million, a 597.44% increase from a year earlier, with the FY2025 full-year figure at $18.8 million, up 89538.1% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$10.2 million, down from $11.1 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for GKOS reached as high as $15.9 million in Q2 2022 and fell as low as -$10.2 million in Q3 2022.
  • Historically, Change in Accured Expenses has averaged $1.0 million across 5 years, with a median of $565000.0 in 2024.
  • Across the five-year window, Change in Accured Expenses tumbled 421.62% in 2024 and jumped 1280.35% in 2025, its largest moves.
  • Year by year, Change in Accured Expenses stood at $9.1 million in 2022, then slipped by 17.7% to $7.5 million in 2023, then tumbled by 40.61% to $4.4 million in 2024, then surged by 151.59% to $11.1 million in 2025, then sank by 191.51% to -$10.2 million in 2026.
  • Per Business Quant data, the three most recent Change in Accured Expenses figures were -$10.2 million in Q1 2026, $11.1 million in Q4 2025, and $7.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -654.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 123.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -512.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -347.10 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 145.10 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 21.07 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -250.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Glaukos 8.83 Bn 8.73 Bn 117.23 Mn -10.19 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -10.19 Mn
Mar 31, 2026 -10.19 Mn
Dec 31, 2025 11.14 Mn
Dec 31, 2025 11.14 Mn
Sep 30, 2025 7.80 Mn
Sep 30, 2025 7.80 Mn
Jun 30, 2025 6.62 Mn
Jun 30, 2025 6.62 Mn
Mar 31, 2025 -6.73 Mn
Mar 31, 2025 -6.73 Mn
Dec 31, 2024 4.43 Mn
Dec 31, 2024 4.43 Mn
Sep 30, 2024 565,000.00
Sep 30, 2024 565,000.00
Jun 30, 2024 -1.35 Mn
Jun 30, 2024 -1.35 Mn
Mar 31, 2024 -3.62 Mn
Mar 31, 2024 -3.62 Mn
Dec 31, 2023 7.45 Mn
Dec 31, 2023 7.45 Mn